Scholars@Duke publication: Measuring clinically significant chemotherapy-related toxicities using Medicare claims from CALGB breast and lung cancer trial participants

Measuring clinically significant chemotherapy-related toxicities using Medicare claims from CALGB breast and lung cancer trial participants

Publication , Conference

Lamont, EB; Herndon, JE; Weeks, JC; Henderson, IC; Lilenbaum, R; Schilsky, RL; Christakis, NA

Published in: JOURNAL OF CLINICAL ONCOLOGY

June 20, 2007

JOURNAL OF CLINICAL ONCOLOGY

1527-7755

0732-183X

June 20, 2007

AMER SOC CLINICAL ONCOLOGY

APA

Chicago

ICMJE

MLA

NLM

Lamont, E. B., Herndon, J. E., Weeks, J. C., Henderson, I. C., Lilenbaum, R., Schilsky, R. L., & Christakis, N. A. (2007). Measuring clinically significant chemotherapy-related toxicities using Medicare claims from CALGB breast and lung cancer trial participants. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 25). AMER SOC CLINICAL ONCOLOGY.

Lamont, E. B., J. E. Herndon, J. C. Weeks, I. C. Henderson, R. Lilenbaum, R. L. Schilsky, and N. A. Christakis. “Measuring clinically significant chemotherapy-related toxicities using Medicare claims from CALGB breast and lung cancer trial participants.” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 25. AMER SOC CLINICAL ONCOLOGY, 2007.

Lamont EB, Herndon JE, Weeks JC, Henderson IC, Lilenbaum R, Schilsky RL, et al. Measuring clinically significant chemotherapy-related toxicities using Medicare claims from CALGB breast and lung cancer trial participants. In: JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2007.

Lamont EB, Herndon JE, Weeks JC, Henderson IC, Lilenbaum R, Schilsky RL, Christakis NA. Measuring clinically significant chemotherapy-related toxicities using Medicare claims from CALGB breast and lung cancer trial participants. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2007.

JOURNAL OF CLINICAL ONCOLOGY

1527-7755

0732-183X

June 20, 2007

AMER SOC CLINICAL ONCOLOGY